CCL21 and neoplasm: A more advanced delivery system using immunocompetent mice was used to evaluate this either by encoding CCL21 in an adeno-recombinant associated virus to enable its transduction following the intra-tumoral implant [145], or only by directly injecting CCL21 into the tumor cells, both resulting in reduced tumor development [146].